Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Triolab AS
AS
Active
Org 963538952
Jogstadveien 21, 2007
Kjeller
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1992 · 34 years old
41 employees
www.triolab.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Triolab AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
667M
501M
334M
167M
0M
2021: 536M
536M
2021
2022: 332M (-38% vs 2021)
332M
-38%
2022
2023: 273M (-18% vs 2022)
273M
-18%
2023
2024: 298M (+9% vs 2023)
298M
+9%
2024
2025: 337M (+13% vs 2024)
337M
+13%
2025
EBITDA
NOK millions
227M
170M
113M
57M
0M
2021: 182M
182M
2021
2022: 78M (-57% vs 2021)
78M
-57%
2022
2023: 41M (-47% vs 2022)
41M
-47%
2023
2024: 40M (-2% vs 2023)
40M
-2%
2024
2025: 47M (+18% vs 2024)
47M
+18%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
336 959
297 868
273 348
332 158
535 689
Staff expenses
−51 687
−45 788
−43 731
−45 150
−43 880
EBITDA
47 368
40 038
40 634
77 768
181 609
Depreciation & amort.
−2 423
−1 480
−110
−240
−807
EBIT
44 945
38 558
40 524
77 528
180 802
Net financials
471
−27
35
−1 002
−1 156
Profit before tax
45 417
38 531
40 559
76 526
179 646
Tax
9 991
8 482
8 923
16 852
39 522
Net profit
35 425
30 048
31 636
59 674
140 124
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
124 048
113 193
112 440
145 287
261 168
Equity
28 975
29 049
29 001
32 365
32 690
Long-term debt
0
0
0
0
0
Short-term debt
95 074
84 144
83 439
112 923
228 478
Total debt
95 074
84 144
83 439
112 923
228 478
Financial ratios
5-year trend
EBITDA margin
14,1 %
This company
15,8 %
Market median
This company
Market median
11% below market
2021
2025
Equity ratio
23,4 %
This company
38,2 %
Market median
This company
Market median
39% below market
2021
2025
Return on equity
122,3 %
This company
18,4 %
Market median
This company
Market median
565% above market
2021
2025
Net profit margin
10,5 %
This company
8,1 %
Market median
This company
Market median
30% above market
2021
2025
Asset turnover
2,72×
This company
1,12×
Market median
This company
Market median
143% above market
2021
2025
Debt / equity
3,28×
This company
0,62×
Market median
This company
Market median
429% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Triolab AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
